Mid Atlantic Bio Angels

Mid Atlantic Bio Angels (MABA) is a prominent angel investor group established in 2008, specifically dedicated to funding new and emerging life science companies. Based in New York, MABA's core mission is to cultivate a robust life science investment ecosystem within the Mid-Atlantic region. The group comprises experienced life science professionals and investors who leverage their deep industry knowledge to identify and support promising ventures.

MABA's investment approach is structured around monthly meetings where selected companies present their innovations. Following these presentations, the group undertakes a rigorous due diligence process to evaluate potential investments. While individual MABA members typically contribute between $25,000 and $100,000, the group's collective participation in a funding round generally ranges from $200,000 to $1,000,000. This collective investment model allows MABA to provide meaningful early-stage capital to its portfolio companies.

The group seeks companies that demonstrate a clear path to commercialization, possess a strong and capable management team, and offer defensible technology or intellectual property. Their focus is primarily on early-stage ventures within the biotechnology, pharmaceutical, medical device, and diagnostics sectors. Beyond capital, MABA members often provide valuable mentorship and strategic guidance, leveraging their extensive networks and operational expertise to help portfolio companies navigate the complex landscape of the life sciences industry.